Coral Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 524506 | NSE: | Pharmaceuticals & Drugs | Small Cap

Coral Laboratories Share Price

370.05 -15.55 -4.03%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Coral Laboratories

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Coral Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
14.57
Market Cap:
132.7 Cr.
52-wk low:
217
52-wk high:
498.1

Is Coral Laboratories Ltd an attractive stock to invest in?

1. Is Coral Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Coral Laboratories Ltd is a average quality company.

2. Is Coral Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Coral Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Coral Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Coral Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Coral Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Coral Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 16.7%16.4%18.2%18.3%10.3%7.9%5.1%10.3%5.4%2.8%-
Value Creation
Index
0.20.20.30.3-0.3-0.4-0.6-0.3-0.6-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 50.859.47795.592.591.170.696.675.678.166
Sales YoY Gr.-17%29.6%24%-3.1%-1.5%-22.5%36.8%-21.7%3.3%-
Adj EPS 2225.232.946.232.625.416.637.922.611.725.5
YoY Gr.-14.9%30.2%40.5%-29.3%-22.1%-34.8%128.6%-40.4%-48.3%-
BVPS (₹) 141.6165.4196.4305.5325.6318.5323.8382.5436.8433.3487.6
Adj Net
Profit
7.9911.716.511.79.15.913.68.14.29
Cash Flow from Ops. 10.45.110.813.5-0.9-3.90.96.112.7-
Debt/CF from Ops. 0.23.70.10.20.1-1.6-1.56.710-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.9%-3.3%3.4%3.3%
Adj EPS -6.8%-18.6%-11%-48.3%
BVPS13.2%5.9%10.2%-0.8%
Share Price 16% 3.2% 3.4% 68.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
16.716.518.218.410.37.95.210.75.52.75.5
Op. Profit
Mgn %
19.920.821.424.416.613.67.716.410.94.911.9
Net Profit
Mgn %
15.415.215.217.312.6108.41410.75.413.7
Debt to
Equity
0000000.10.100-
Working Cap
Days
224235241229243247332273382346377
Cash Conv.
Cycle
92130127127140129181146213180337

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 5.50%

Sales growth has been subdued in last 3 years 3.44%

Net Profit has been subdued in last 3 years -11.01%

Sales growth is not so good in last 4 quarters at -24.12%

Latest Financials - Coral Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 25.5 -
TTM Sales (₹ Cr.) 66.2 -
BVPS (₹.) 487.6 -
Reserves (₹ Cr.) 171 -
P/BV 0.76 -
PE 14.57 -
From the Market
52 Week Low / High (₹) 217.00 / 498.10
All Time Low / High (₹) 7.25 / 1190.00
Market Cap (₹ Cr.) 133
Equity (₹ Cr.) 3.6
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Coral Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Coral Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales51597795929171977678
Operating Expenses 41476172777965816774
Manufacturing Costs14182232252819262122
Material Costs20212729363227322631
Employee Cost 445791010101111
Other Costs 3475899131010
Operating Profit 10121623151251684
Operating Profit Margin (%) 19.9%20.8%21.4%24.4%16.6%13.6%7.7%16.4%10.9%4.9%
Other Income 1333456457
Interest 0000000000
Depreciation 1322222222
Exceptional Items 0000000010
Profit Before Tax 101217251816918128
Tax 2358652432
Profit After Tax 8101216121071496
PAT Margin (%) 15.5%16.1%16.1%17.1%13.5%11.2%10.1%14.0%12.0%8.3%
Adjusted EPS (₹)22.026.834.745.634.828.620.037.925.318.0
Dividend Payout Ratio (%)9%9%9%11%6%7%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 515970109116114116137156155
Share Capital 4444444444
Reserves 475567106113110112133152151
Minority Interest0000000000
Debt0102216660
Long Term Debt0000000000
Short Term Debt0102216660
Trade Payables5610101313141594
Others Liabilities 56910989101915
Total Liabilities 607289131140136144168190174

Fixed Assets

Gross Block31333432373940414649
Accumulated Depreciation11141614151719212325
Net Fixed Assets20191818212222202324
CWIP 0000000120
Investments 11539462926334641
Inventories8101321181619221813
Trade Receivables15252831323034393823
Cash Equivalents 77912112330353740
Others Assets9101710121513182532
Total Assets 607289131140136144168190174

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 1051113-1-41613
PBT 101217251816918118
Adjustment 0100111000
Changes in Working Capital -6-10-6-50-13-13-13-06
Tax Paid -2-2-5-9-6-5-1-3-4-2
Cash Flow From Investing Activity 10-3-10-133-20-6-3
Capex 0-2-1-2-5-3-1-1-6-2
Net Investments 00-3-9-9500-2-2
Others 1121110121
Cash Flow From Financing Activity 0000-3-1400-6
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 000-1-2-1-1000
Others 000200400-6
Net Cash Flow 2021-21-2104
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)16.7217.4619.1818.1711.048.886.2210.746.184.15
ROCE (%)21.2422.2226.9327.2315.9113.447.8613.357.875.41
Asset Turnover Ratio0.880.920.970.870.680.660.50.620.420.43
PAT to CFO Conversion(x)0.1300.420.691.08-0.1-0.570.070.672.17
Working Capital Days
Receivable Days90119122112123124167139187144
Inventory Days59565565766892779772
Payable Days10910110712611614418116516776

Coral Laboratories Ltd Stock News

Coral Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Coral Laboratories on 28-Mar-2024 16:01 is ₹370.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Coral Laboratories stood at ₹132.7.
The latest P/E ratio of Coral Laboratories as of 28-Mar-2024 16:01 is 14.57.
The latest P/B ratio of Coral Laboratories as of 28-Mar-2024 16:01 is 0.76.
The 52-week high of Coral Laboratories is ₹498.1 and the 52-week low is ₹217.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Coral Laboratories is ₹66.21 ( Cr.) .

About Coral Laboratories Ltd

Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

The Company with deep basket of products is focused in hostlic human welfare and is bringing planfort to people with its Inflammatory, Bacterial, Biotic, Protein deficiencies & Skin conditions. Medicines across the nation, manufactured under the ZEST group & MOXBRO group being the most popular brands across the nation, manufactured by the company.Coral Laboratories has been following a steady growth path on the pillars of its philosophy of “Total Quality Management” & “Quality Products at Affordable Prices”.

The state-of-the art manufacturing facilities meet the stringent and over changing quality requirement of the most discerning buyers. Coral has a multi location manufacturing facilities based on Baroda, Daman & Vasai for strategies convenience. The facilities carrying WHO-GMP & ISO 9001 : 2000 certification. The new manufacturing facilities under expansion to have UK – MHRA and US– FDA certification.

Coral has one of the best quality control laboratory in indian pharmaceuticals industry equipped with latest and sensitive laboratory instruments.

Product range of the company includes:

  • Capsules & Dry Syrups
  • Tablets
  • Liquid Orals
  • Kits
  • Ointment & Cream
  • Injection – Eye – Ear Drops
  • Others

Achievements/ recognition:

  • WHO GMP certification issued by the Food & Drugs Control Administration
  • ISO 9001-2000 Quality certification issued by American Quality Assessors.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.